Rebekka Drew Miller, NP

Rebekka Miller practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Rebekka Miller's NPI, 1154975977, was assigned on July 30, 2019. Rebekka Miller holds California license 95029684.

Rebekka Miller's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Rebekka Miller's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Rebekka Miller is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Rebekka Miller to 1 more hospital and 2 medical groups, each named with a free account. Rebekka Miller's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Rebekka Miller practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Rebekka Miller's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Dmand AI has Rebekka Miller's licenses on file in 3 states: California, Maine and Virginia.

Dmand AI lists anxiety, arthritis, bursitis, chronic diabetes, enthesopathy in arms, fibromyalgia and chronic pain, insomnia and joint or bone infection among the conditions Rebekka Miller treats.

CMS data shows 181 Medicare services from Rebekka Miller across 2 procedure codes in 2024, all of them office visits, for 199 Medicare patients. Medicare paid $6,792 for them. Every service was in an office.

CMS counts 199 Medicare patients who saw Rebekka Miller in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have arthritis, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Rebekka Miller's median patient age at 63, with 54% women.

In 2024, Rebekka Miller wrote 1,014 Medicare Part D claims for 281 patients. 89% of them were for generic drugs. CMS names the drug for 846 of them, across 19 drugs with 11 or more claims each, at $58,133 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Rebekka Miller for performance year 2024, reported as part of a group. Rebekka Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rebekka Miller as offering telehealth.

CMS Open Payments shows 5 general payments to Rebekka Miller from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $112.